Literature DB >> 22331950

Fast and flawed or scientifically sound: the argument for administering oral oncology drugs during fasting.

Mary Todd, Michael L Meyers, Robert Charnas, Milin Acharya, Arturo Molina.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22331950     DOI： 10.1200/JCO.2011.39.7851

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  Abiraterone in the treatment of metastatic castration-resistant prostate cancer.

Authors:  Elahe A Mostaghel
Journal:  Cancer Manag Res       Date:  2014-01-28       Impact factor: 3.989

Review 2.  Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer.

Authors:  Mark N Stein; Neal Patel; Alexander Bershadskiy; Alisa Sokoloff; Eric A Singer
Journal:  Asian J Androl       Date:  2014 May-Jun       Impact factor: 3.285

3.  Effect of high-fat diet on the pharmacokinetics and safety of flumatinib in healthy Chinese subjects.

Authors:  Yun Kuang; Hui-Ling Song; Guo-Ping Yang; Qi Pei; Xiao-Yan Yang; Ling Ye; Shuang Yang; Shu-Ting Wu; Can Guo; Qing-Nan He; Jie Huang
Journal:  Cancer Chemother Pharmacol       Date:  2020-08-05       Impact factor: 3.288
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.